An observational study in Adolescence Idiopathic Scoliosis, sponsored by Hacettepe University. Enrolling by invitation at 1 site in Turkey (Türkiye). Open to female participants aged 10 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-05.
Sponsored by Hacettepe University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Scoliosis by Hacettepe University — 4 open to participants now, 4 under way, none of them phase 3. Scoliosis · Hacettepe University.
Among the 15 studies in Scoliosis by Hacettepe University, this one is the only one that started in 2025, is one of 4 observational ones, and was the 14th registered.
660 studies on the registry are indexed under Scoliosis; 185 are open to participants now.
Browse Scoliosis studies →4 of the 15 studies in Scoliosis by Hacettepe University are open now, in 1 country. Recruiting first, the newest first:
Hacettepe University · Sites in Turkey
Ages 10–18 · Women only
Hacettepe University
Ages 18–21 · Healthy volunteers
Hacettepe University · Sites in Turkey
Ages 10+ · Healthy volunteers
By country, each count listing its studies:
Of the 117 Scoliosis studies recruiting now, 23 (20%) set no upper age limit and 88 (75%) stop at 75 or younger; 98 take children under 18; 14 take healthy volunteers.
This study: 10 Years to 18 Years · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
First in 2015; this study’s year is marked. 1 started in 2025.
This study's planned enrollment of 50 is below the median of 84 across 256 observational studies indexed under Scoliosis.
Median enrollment 40 across the 11 interventional studies, 59 across the 4 observational. Of the 11 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Hacettepe University is the lead sponsor of 1,009 studies on the registry; 214 are open to participants now.
1 of the studies in Scoliosis by Hacettepe University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07321600Hacettepe UniversityResisted Inspiratory Muscle Training Applied in Addition to PSSE-Schroth Exercises | 2026-12-02 |
Add it to your calendar (.ics) → With an account.
Among the 15 studies in Scoliosis by Hacettepe University, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Adolescent idiopathic scoliosis (AIS) leads to three-dimensional spinal deformity during adolescence, causing deviations in the frontal, sagittal, and axial planes, impairing physical function, balance, and lumbopelvic rhythm. Individuals with AIS exhibit decreased trunk movement, muscle overactivation, increased energy expenditure, balance/gait disturbances, and abnormalities in proprioceptive/vestibular input; pressure center deviations increase in postural control. These changes negatively impact daily life, pain, and quality of life.
Although the literature has examined the relationships between AIS and muscle activation, range of motion, pelvic position, and gait/balance, the relationship between lumbopelvic rhythm changes and curve type/localization/severity, and its impact on postural control and quality of life, has not been investigated. This study aims to elucidate movement patterns by evaluating lumbopelvic rhythm in individuals with AIS and to guide clinical diagnosis/treatment.
Adolescent idiopathic scoliosis (AIS) is a condition that emerges during adolescence and causes a three-dimensional deformity of the spine. This deformity can cause deviations in frontal, sagittal, and axial flight, negatively impacting physical function and balance control mechanisms. Lumbopelvic rhythm ensures the coordination of spinal and pelvic movements and is a critical factor for postural stability. Scoliosis can disrupt lumbopelvic rhythm by affecting pelvic and lumbar region movements. Individuals with AIS have been observed to exhibit changes such as decreased trunk flexion-extension movements and pelvic and hip movements during gait, overactivity of muscles involved in the spine and pelvis, increased energy expenditure, and changes in balance and limb alignment. Abnormalities in vestibular and proprioceptive input have also been observed, leading to changes in balance control. Postural control requires the integration of sensory and motor systems to maintain body balance. In individuals with scoliosis, changes in postural control can reduce mobility. Assessments of postural control, when compared to healthy individuals, have shown that those with scoliosis exhibit higher deviations and acceleration rates in pressure points. This can lead to difficulties in daily living activities, increased pain levels, and decreased quality of life. While the literature examines muscle activation, spinal range of motion, pelvic position, gait, and balance in individuals with AIS, studies on the distribution of lumbopelvic rhythm and its relationship to curvature type, localization, and work, as well as the impact of lumbopelvic rhythm on postural control and quality of life, have not been found. Therefore, evaluating lumbopelvic rhythm in individuals with AIS can contribute to a comprehensive understanding of changes in scoliosis-related movement patterns, guiding clinical diagnosis and treatment.
The study group will consist of individuals diagnosed with AIS who apply to the Faculty of Physical Therapy and Rehabilitation at Hacettepe University. Participants in the healthy group will be selected using a snowball method from among the relatives of patients who apply to the Faculty of Physical Therapy and Rehabilitation or from among the relatives of the researchers.
Inclusion Criteria:
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Adolescent idiopathic scoliosis 10-18 age
Lumbopelvic rhythm,
An Inertial Measurement Unit (IMU) will be used to assess lumbopelvic rhythm
Time frame: January 30, 2025 - October 8, 2026
Postural control
Postural control will be assessed using the Bertec Balance Check Screener™ strength platform (BP5050 Bertec Co., Columbus, OH, USA) (13).
Time frame: January 30, 2025 - October 8, 2026
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Started Dec 2025 (actual). Primary completion is estimated for Apr 2026, 3 months after the start.
Of 94 non-industry observational studies under Scoliosis, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 99. This study's planned 3 months is below that.
Counting every sponsor, half of 106 studies reached it within 36 months; a quarter within 9 and three quarters within 92.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.